Severe persistent visual field constriction associated with vigabatrin. Benefit: risk ratio must be calculated for individual patients.
Publisher: BMJ Group
Sorry, we are unable to provide the full text but you may find it at the following location(s):
http://www.pubmedcentral.nih.g... (external link)